Vertaling van "area of public health at a european level " (Nederlands → Frans) :

The Council has restricted itself to the 3 main ingredients of these drinks, viz. caffeine, taurine and D-glucuronolactone, while taking into account the opinion of the counselling authorities in the area of public health at a European level and in several countries of the European Union.
C’est donc en s’en tenant aux 3 composants principaux de ces boissons, la caféine, la taurine et le D-glucuronolactone, que le Conseil a dès lors pris en compte les avis rendus par des instances de Conseil en Santé publique au niveau européen ou dans plusieurs pays de l’Union.

On the other hand, the federal Minister of Public Health points out that, until harmonised provisions have been introduced at the European level, caffeine falls under the food additives legislation in Belgium and that this harmonisation will be carried out in a different context than the food additives legislation.
Par ailleurs, le Ministre Fédéral de la Santé Publique précise clairement que la caféine relève en Belgique de la législation sur les additifs jusqu’à ce qu’une harmonisation soit opérée à l’échelon européen et que cette harmonisation se fera dans un autre cadre que celui de la législation sur les additifs.

Given the lack of a unified approach to energy drinks at a European level, the Superior Health Council confirms its reservations about these energy drinks. More particularly, it recommends that they should not be consumed:
En l’absence d’une approche unifiée des boissons énergisantes au niveau européen, le Conseil Supérieur de la Santé réaffirme ses réserves à leur égard et recommande notamment de:

BIJLAGE 6 Mental Health Expenditure in European Economic Area countries (% of total health expenditure)
ANNEXE 6 Dépenses de santé mentale dans les pays de l’Espace économique européen (en % du montant total des dépenses de santé)

and Public Health Minister’s office “Grey area” consultation platform (with FPS Economie, FPS Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Economie, FPS Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Economie, FPS
and Public Health Minister’s office “Grey area” consultation platform (with FPS Economie, FPS Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Economie, FPS Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Economie, FPS

Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office DGO - SCM guidance committee (with APB and OPHACO) e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees ICVV – CICSA Influenza (in cooperation with external partners) Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Inter DG drugs (with FPS Public Health) Mdeon board of management Potassium iodide tablets campaign (with FPS Interior Affairs) Provincial medical commissions (with FPS Public Health) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI)
Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office DGO - SCM guidance committee (with APB and OPHACO) e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees ICVV – CICSA Influenza (in cooperation with external partners) Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Inter DG drugs (with FPS Public Health) Mdeon board of management Potassium iodide tablets campaign (with FPS Interior Affairs) Provincial medical commissions (with FPS Public Health) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI)

International representation Medicines and health products are the subject of extensive legislative harmonisation at European Community level.
International representation Medicines and health products are the subject of extensive legislative harmonisation at European Community level.

Lower benchmark dose Contaminants in the food chain Koper European Food Safety Authority Federaal agentschap voor de veiligheid van de voedselketen Ijzer Scientific Institute of Public Health Joint Expert Committee WHO/FAO on Food Additives Lichaamsgewicht Margin of Exposure Nikkel Lood Provisional tolerable weekly intake Toelaatbare dagelijkse inname Toxicologische referentiewaarde World Health Organization Wetenschappelijk Instituut Volksgezondheid Zink
AFSCA Agence fédérale pour la sécurité de la chaîne alimentaire BMDL Lower benchmark dose CONTAM Contaminants in the food chain CSS Conseil Supérieur de la Santé Cu Cuivre DJT Dose journalière tolérable EFSA European Food Safety Authority Fe Fer IPH Scientific Institute of Public Health ISP Institut Scientifique de la Santé Publique JECFA Joint Expert Committee WHO/FAO on Food Additives MoE Margin of Exposure Ni Nickel pc poids corporel Pb Plomb PTWI Provisional tolerable weekly intake VTR Valeur toxicologique de référence WHO World Health Organization Zn Zinc

vCJD transmission by blood », European Commission Health and Consumer Protection Directorate-General, October 2004, 13 bladzijden. d) Enquête EC Public Health and Risk Assessment « Precautionary measures against
vCJD transmission by blood », European Commission Health and Consumer Protection Directorate-General, October 2004, 13 pages. d) Enquête EC Public Health and Risk Assessment « Precautionary measures against

Niet-overheidsorganisatie: Andrew Hayes, European Public Health Alliance (EPHA)
Organisations non-gouvernementales: Andrew Hayes, Alliance Européenne pour la Santé Publique (EPHA)